Zydus Lifesciences Share Price Jumps to Fresh 52-Week High at Rs 1,216: Here’s Why
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Zydus Lifesciences Share Price was Rs 1,204.75 on 28 September 2026 at 9:18 AM IST, up 0.23% from the previous close of Rs 1,202, after the stock touched a fresh 52-week high of Rs 1,215.65 during the session. The company’s market capitalisation stood at Rs 1,19,899.96 crore. This Zydus Lifesciences Share Price move places the stock in current market focus because it set a new yearly high even as the day’s close remained below the session peak. The available data confirms the price event, while it does not establish a company-specific catalyst. For readers following Zydus Lifesciences Share Price Today, the relevant facts are the intraday range, the fresh 52-week high and the company’s valuation profile across the healthcare and pharmaceuticals space.
For Zydus Lifesciences Stock News, the event matters because it combines a new annual peak with a measured day-on-day gain rather than a sharp gap move. Zydus Lifesciences Share News around such events is typically read alongside market cap, earnings metrics and sector positioning. Univest tracks the same data points so investors can review Zydus Lifesciences Share Price Live, Zydus Lifesciences Latest News and the company’s broader Stock Performance in one place.
Zydus Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,204.75 |
| Previous Close | Rs 1,202 |
| Today's Move | +Rs 2.75 (+0.23%) |
| Open | Rs 1,213.95 |
| High | Rs 1,215.65 |
| Low | Rs 1,203 |
| Turnover | Rs 1.77 crore |
| Market Capitalisation | Rs 1,19,899.96 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,204.75 versus the previous close of Rs 1,202, a rise of 0.23%. The stock opened at Rs 1,213.95, reached a high of Rs 1,215.65 and touched a low of Rs 1,203.
Zydus Lifesciences Share Price Today shows a session that opened at Rs 1,213.95, moved between Rs 1,203 and Rs 1,215.65, and settled at Rs 1,204.75. The stock touched its fresh 52-week high at Rs 1,215.65, which also matched the day’s high, and finished Rs 2.75 above the previous close of Rs 1,202. Turnover stood at Rs 1.77 crore. The price event confirms that Zydus Lifesciences Share Price reached a yearly high in the current session, while the closing level remained just below that peak. That makes the move relevant for readers tracking Zydus Lifesciences Share Price Update, Zydus Lifesciences NSE and Zydus Lifesciences BSE market behaviour. On the verified numbers, the stock moved higher on the day and printed a fresh 52-week high, which is the central fact in today’s Zydus Lifesciences Stock News.
From a market update perspective, this is a clean price event with a narrow day range relative to the high. Zydus Lifesciences Share Price News today therefore centres on the session high, the close and the modest percentage change rather than any unverified trigger.
Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,19,899.96 crore |
| P/E Ratio | 26.57x |
| P/B Ratio | 4.45x |
| ROE | 19.69% |
| ROCE | 21.39% |
| EPS | Rs 45.24 |
| Book Value Per Share | Rs 270.31 |
| Dividend Yield | 0.08% |
Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 26.57x, P/B 4.45x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.
Zydus Lifesciences Ltd. has a market capitalisation of Rs 119899.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.57x, P/B at 4.45x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.98x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.57x |
| Benchmark Median P/E | 32.98x |
| Benchmark Average P/E | 49.76x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 4.45x |
| Benchmark Median P/B | 2.84x |
| Company ROE | 19.69% |
| Benchmark Median ROE | 11.43% |
| Company ROCE | 21.39% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 1,19,899.96 crore |
| Benchmark Median Market Cap | Rs 722.23 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.57x, which is below the benchmark median of 32.98x, a difference of -19.44%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.43%, a difference of +72.27%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.1%, a difference of +63.28%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,08,116.47 | 98.88 | 19.17 | 18.31 | 18.2 |
| Mankind Pharma Ltd. | MANKIND | 1,02,247.25 | 50.06 | 6.08 | 12.69 | 13.24 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,00,395.34 | 31.16 | 2.63 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 98,464.42 | 26.52 | 2.53 | 9.93 | 12.76 |
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.57x compared with the displayed peer median of 33.49x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.69% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,19,899.96 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Zydus Lifesciences
- Zydus Lifesciences Share Price touched Rs 1,215.65, a fresh 52-week high in the current session.
- The stock finished at Rs 1,204.75, up Rs 2.75 or 0.23% from the previous close of Rs 1,202.
- Market capitalisation stood at Rs 1,19,899.96 crore.
- P/E was 26.57, P/B was 4.45, ROE was 19.69% and ROCE was 21.39%.
- Within the supplied peer set, the company’s ROE and ROCE were above Cipla, Dr. Reddy’s and Aurobindo Pharma.
About Zydus Lifesciences
Zydus Lifesciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is identified here through its listed market profile on NSE and BSE, with the current event centred on Zydus Lifesciences Share Price and the fresh 52-week high. The supplied data places the company in a large-capitalisation market context by market value, but the only facts used here are the listed sector, industry and financial metrics. Univest uses this company profile to connect Zydus Lifesciences Share Price with Zydus Lifesciences Stock News, Zydus Lifesciences Company News and broader market updates for investors comparing the stock with its healthcare peers.
Track Zydus Lifesciences Share Price on Univest
Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
On Univest, readers can track Zydus Lifesciences Share Price, Zydus Lifesciences Share Price Today, Zydus Lifesciences Share Price Live and Zydus Lifesciences Stock Analysis alongside market cap, PE ratio, PB ratio, EPS, book value and shareholding pattern. Univest also helps users follow the 52-week high, 52-week low, sector context and peer comparison in one view, making Zydus Lifesciences Share Price easier to monitor through each market update.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Zydus Lifesciences Share Price?
Ans. Zydus Lifesciences Share Price was Rs 1,204.75 at 9:18 AM IST on 28 September 2026. The stock gained 0.23% from the previous close of Rs 1,202 and also touched a fresh 52-week high.
What is the fresh 52-week high for Zydus Lifesciences Share Price?
Ans. The fresh 52-week high for Zydus Lifesciences Share Price was Rs 1,215.65. That level was also the day’s high, and the stock later settled below it at Rs 1,204.75. The stock moved 0.23% during the session.
How much did Zydus Lifesciences Share Price move today?
Ans. Zydus Lifesciences Share Price rose by Rs 2.75, or 0.23%, versus the previous close. The session opened at Rs 1,213.95 and traded between Rs 1,203 and Rs 1,215.65. The stock moved 0.23% during the session.
What is the market capitalisation of Zydus Lifesciences?
Ans. Zydus Lifesciences has a market capitalisation of Rs 1,19,899.96 crore. That places the company well above the same-industry median of Rs 722.23 crore in the supplied benchmark set. The company operates in the Healthcare sector.
What does Zydus Lifesciences Fundamental Analysis show?
Ans. Zydus Lifesciences Fundamental Analysis shows a P/E of 26.57, P/B of 4.45, ROE of 19.69% and ROCE of 21.39%. EPS is Rs 45.24 and book value per share is Rs 270.31.
How does Zydus Lifesciences compare with peers?
Ans. In the supplied peer set, Zydus Lifesciences shows a lower P/E than Cipla and Dr. Reddy’s, while its ROE and ROCE are higher than Cipla, Dr. Reddy’s and Aurobindo Pharma.
What sector does Zydus Lifesciences belong to?
Ans. Zydus Lifesciences belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark covers 203 same-industry companies and 292 companies in the same sector. The stock belongs to the Healthcare sector.
Why is Zydus Lifesciences Share Price in news today?
Ans. Zydus Lifesciences Share Price is in news today because it touched a fresh 52-week high of Rs 1,215.65. The verified data confirms the price event, though it does not establish a specific catalyst.
Where can I track Zydus Lifesciences Share Price Today?
Ans. Zydus Lifesciences Share Price Today can be tracked on Univest with live price context, 52-week levels, valuation ratios, earnings data and sector comparison, all in one place for quick reference.
